Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Piotr Kuna, Marek Jutel, Grazyna Pulka, Slawomir Tokarski, Paula Arranz, Gonzalo Hernández & Nieves Fernández Hernando. (2023) Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study. Clinical Ophthalmology 17, pages 735-746.
Read now
Read now
Antonio Nieto, María Nieto & Ángel Mazón. (2021) The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine. Expert Opinion on Pharmacotherapy 22:4, pages 511-519.
Read now
Read now
Martin K. Church, Marysia Tiongco-Recto, Erminia Ridolo & Zoltán Novák. (2020) Bilastine: a lifetime companion for the treatment of allergies. Current Medical Research and Opinion 36:3, pages 445-454.
Read now
Read now
Rossen Boev & Jürgen WG Bentz. (2016) Balanced discussion of second-generation antihistamines’ data. Therapeutics and Clinical Risk Management 12, pages 1777-1781.
Read now
Read now
Xue Yan Wang, Margaret Lim-Jurado, Narayanan Prepageran, Pongsakorn Tantilipikorn & De Yun Wang. (2016) Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Therapeutics and Clinical Risk Management 12, pages 585-597.
Read now
Read now
Ludger Klimek, Joaquim Mullol, Peter Hellings, Philippe Gevaert, Ralph Mösges & Wytske Fokkens. (2016) Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis. Expert Opinion on Pharmacotherapy 17:5, pages 657-669.
Read now
Read now
Erminia Ridolo, Marcello Montagni, Valerie Melli, Fulvio Braido, Cristoforo Incorvaia & Giorgio Walter Canonica. (2014) Pharmacotherapy of allergic rhinitis: current options and future perspectives. Expert Opinion on Pharmacotherapy 15:1, pages 73-83.
Read now
Read now
Belen Sadaba, Jose Ramon Azanza, Almundena Gomez-Guiu & Raquel Rodil. (2013) Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria. Therapeutics and Clinical Risk Management 9, pages 197-205.
Read now
Read now
Ignacio Jáuregui, Marta Ferrer, Joan Bartra, Alfonso del Cuvillo, Ignacio Dávila, Javier Montoro, Joaquim Mullol, Joaquín Sastre & Antonio Valero. (2013)
Bilastine for the treatment of urticaria. Expert Opinion on Pharmacotherapy 14:11, pages 1537-1544.
Read now
Read now
Giovanni Passalacqua & Giorgio Ciprandi. (2012) Emerging drugs for perennial allergic rhinitis. Expert Opinion on Emerging Drugs 17:4, pages 543-553.
Read now
Read now
Articles from other publishers (36)
Yuhang Chen, Jie Wang, Liqun Wu, Ye Zhang, Hong Chen & Ziwei Zhang. (2023) Efficacy of Chinese herbal medicine on nasal itching in children with allergic rhinitis: a systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Sophia Linton, Lubnaa Hossenbaccus & Anne K. Ellis. (2023) Evidence-based use of antihistamines for treatment of allergic conditions. Annals of Allergy, Asthma & Immunology.
Crossref
Crossref
Aliaa M. Abdelshafy, Sara Y. Abdallah, Ahmed F. Hassan, Hazem A. Mohamed, Nourhan M. Kamal, Sohila T. Ali & Ibrahim A. Abdelhaleem. (2022) The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Rhinology & Allergy 36:5, pages 684-694.
Crossref
Crossref
Su Won Lee, Jin Kwan Choi, Yee Ran Lyu, Won Kyung Yang, Seung Hyung Kim, Je Hyun Kim, Si Yeon Kim, Weechang Kang, In Chul Jung, Beom Joon Lee, Jun Yong Choi, Taesoo Kim & Yang Chun Park. (2022) Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-8.
Crossref
Crossref
Aranjit Singh Randhawa, Norhayati Mohd Noor, Mohd Khairi Md Daud & Baharudin Abdullah. (2022) Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Alexander V. Emelyanov, Galina R. Sergeeva & Evgenia V. Leshenkova. (2021) Modern H1- antihistamines in the treatment of allergic rhinitis: focus on bilastine. Russian Journal of Allergy 18:2, pages 66-76.
Crossref
Crossref
Antonio Valero, Iñaki Izquierdo, Marek L. Kowalski, Glenis K. Scadding, Jean Bousquet & Joaquim Mullol. (2020) Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis. Allergy, Asthma & Clinical Immunology 16:1.
Crossref
Crossref
S. Ryazantsev, I. Gogunska, I. Lymar, L. Romanyuk, B. Bil, S. Pukhlik, V. Pravdyva, V. Lapshyn & V. Koshlia. (2019) The Efficacy and Safety of Bilastine in the Treatment of Perennial Allergic Rhinitis in Patients with Moderate and Severe Forms of the Disease. Comparison of bilastine 20 mg with desloratadine 5 mg Сергей. Medical Council:20, pages 58-67.
Crossref
Crossref
S. V. Ryazantsev, A. A. Krivopalov, S. A. Rebrova & L. I. Krivopalova. (2019) New possibilities for symptomatic treatment of allergic rhinitis. Medical Council:6, pages 64-67.
Crossref
Crossref
Hideyuki Kawauchi, Kazuhiko Yanai, De-Yun Wang, Koju Itahashi & Kimihiro Okubo. (2019) Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties. International Journal of Molecular Sciences 20:1, pages 213.
Crossref
Crossref
A. A. Krivopalov, S. A. Rebrova & L. I. Krivopalova. (2018) New possibilities of pathogenetic therapy for allergic rhinitis. Medical Council:20, pages 89-91.
Crossref
Crossref
Yu. N. Perlamutrov, K. B. Olkhovskaya & A. O. Lyapon. (2018) Antihistamines in dermatological practice. Klinicheskaya dermatologiya i venerologiya 17:2, pages 62.
Crossref
Crossref
E S Fedenko, O A Erina & O G Elisyutina. (2017) Efficacy and safety of bilastine in allergic diseases therapy. Russian Journal of Allergy 14:1, pages 54-59.
Crossref
Crossref
Kimihiro Okubo, Minoru Gotoh, Michinori Togawa, Akihiro Saito & Yoshihiro Ohashi. (2017) Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial. Auris Nasus Larynx 44:3, pages 294-301.
Crossref
Crossref
Akiko Yagami, Masutaka Furue, Michinori Togawa, Akihiro Saito & Michihiro Hide. (2017) One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases. The Journal of Dermatology 44:4, pages 375-385.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2017) Bilastine in symptomatic allergic rhinoconjunctivitis and urticaria: a guide to its use. Drugs & Therapy Perspectives 33:3, pages 102-109.
Crossref
Crossref
A. A. Krivopalov, O. I. Konoplev, S. V. Shervashidze & V. A. Shatalov. (2017) NEW ORIGINAL ANTIHISTAMINE BILASTINE IN THE TREATMENT OF ALLERGIC RHINITIS. Medical Council:16, pages 88-90.
Crossref
Crossref
Kimihiro Okubo, Minoru Gotoh, Mikiya Asako, Yasuyuki Nomura, Michinori Togawa, Akihiro Saito, Takayuki Honda & Yoshihiro Ohashi. (2017) Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study. Allergology International 66:1, pages 97-105.
Crossref
Crossref
Piotr Kuna, Dariusz Jurkiewicz, Magdalena M. Czarnecka-Operacz, Rafał Pawliczak, Jarosław Woroń, Marcin Moniuszko & Andrzej Emeryk. (2017) The role and choice criteria of antihistamines in allergy management – Expert opinion. Alergologia Polska - Polish Journal of Allergology 4:1, pages 7-19.
Crossref
Crossref
Chunhui Wei. (2016) The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis. Biomedicine & Pharmacotherapy 83, pages 989-997.
Crossref
Crossref
Giuseppina Rotiroti, M. Dziadzio & M. Radcliffe. (2016) Antihistamines for the Treatment of Allergic Rhino-conjunctivitis. Current Treatment Options in Allergy 3:1, pages 1-17.
Crossref
Crossref
Davide Caimmi, Moises A. Calderon, Jean Bousquet & Pascal Demoly. (2016) Allergen Immunotherapy Outcomes and Unmet Needs. Immunology and Allergy Clinics of North America 36:1, pages 181-189.
Crossref
Crossref
Ralph MösgesDennis Lip Yen LeeJovilia AbongBella SiasocoSteven KW ChowJern-Lin LeongHarvinder SinghS KuljitBenjamin Campomanes. (2016) Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement. Asia Pacific Allergy 6:1, pages 56.
Crossref
Crossref
Erminia Ridolo, Marcello Montagni, Laura Bonzano, Cristoforo Incorvaia & Giorgio Walter Canonica. (2015) Bilastine: new insight into antihistamine treatment. Clinical and Molecular Allergy 13:1.
Crossref
Crossref
Oliver Pfaar, Ludger Klimek & Roy Gerth van Wijk. (2015) Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis. Current Opinion in Allergy & Clinical Immunology 15:3, pages 197-203.
Crossref
Crossref
Pascal Demoly, Anca Mirela Chiriac, Benoît Berge & Michel Rostin. (2014) Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response. Allergy, Asthma & Clinical Immunology 10:1.
Crossref
Crossref
Krzysztof Kowal & Lawrence DuBuske. (2014) Bilastine as a Potential Treatment in Allergic Rhinitis. American Journal of Rhinology & Allergy 28:4, pages 312-316.
Crossref
Crossref
Rafał Pawliczak. (2014) Leczenie pokrzywki przewlekłej: zwiększanie dawek leków przeciwhistaminowych – kryteria wyboru terapii. Alergologia Polska - Polish Journal of Allergology 1:3, pages 102-107.
Crossref
Crossref
Garry M. Walsh. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
295
307
.
Sabine Vits, Elvir Cesko, Sven Benson, Annika Rueckert, Uwe Hillen, Dirk Schadendorf & Manfred Schedlowski. (2013) Cognitive Factors Mediate Placebo Responses in Patients with House Dust Mite Allergy. PLoS ONE 8:11, pages e79576.
Crossref
Crossref
Kenneth C. Lasseter, Ander Sologuren, Anna La Noce & Stacy C. Dilzer. (2013) Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency. Clinical Drug Investigation 33:9, pages 665-673.
Crossref
Crossref
Vardhamane S.H & Jeevangi Santoshkumar. (2013) ANTI-INFLAMMATORY ACTIVITY OF H1 RECEPTOR ANTAGONIST CETIRIZINE IN ANIMAL MODELS. Journal of Evolution of medical and Dental Sciences 2:13, pages 2050-2059.
Crossref
Crossref
Luo Zhang, Lei Cheng & Jianguo Hong. (2013) The Clinical Use of Cetirizine in the Treatment of Allergic Rhinitis. Pharmacology 92:1-2, pages 14-25.
Crossref
Crossref
Ole D. Wolthers. (2013) Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria. BioMed Research International 2013, pages 1-6.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Natalie A. Carter. (2012) Bilastine: a guide to its use in the treatment of symptomatic allergic rhinoconjunctivitis and urticaria. Drugs & Therapy Perspectives 28:11, pages 1-5.
Crossref
Crossref
Natalie J. Carter. (2012) Bilastine. Drugs 72:9, pages 1257-1269.
Crossref
Crossref